USFDA completes inspection of Lupin’s Nagpur plant

New Delhi: Pharma major Lupin today said the US health regulator has completed inspection of its Nagpur facility without making any observations.

In a BSE filing, Lupin “announced successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection concluded without any observations”.

Lupin said its Nagpur facility manufactures oral solid products.

Shares of Lupin were trading 2.09 per cent higher at Rs 767.50 on BSE.

  • Related Posts

    Telangana DCA launches SMS alert system to notify NSQ drugs

    Hyderabad: The Drugs Control Administration (DCA) in Telangana has significantly intensified its crackdown on illegal medical practices while simultaneously launching a high-tech digital shield for public health. On March 9, the…

    Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

    T’puram: Chief minister Pinarayi Vijayan virtually inaugurated a centre of excellence in nutraceuticals (CoEN) at Bio 360 Life Sciences Park, Thonnakkal, on Monday. The initiative, spearheaded by Kerala State Council…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Beware- Glaucoma might steal Your Eyesight Unawares!

    Beware- Glaucoma might steal Your Eyesight Unawares!

    Telangana DCA launches SMS alert system to notify NSQ drugs

    Telangana DCA launches SMS alert system to notify NSQ drugs

    Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

    Centre of Excellence in Nutraceuticals inaugurated by the Hon’ble Chief Minister of Kerala

    ATS Busts Drug Export Racket: 22 Kg Etomidate Seized, Two Arrested Including Nikunj

    ATS Busts Drug Export Racket: 22 Kg Etomidate Seized, Two Arrested Including Nikunj

    Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

    Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier?

    Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads

    Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads